Good morning :)
$
₹
R

Retension Pharmaceuticals, Inc. Common Stock

RTSN

NASDAQ
R

Retension Pharmaceuticals, Inc. Common Stock

RTSN

NASDAQ
$14.594.32% (-0.66)
$
₹
$14.594.32% (-0.66)
High
—
—
Low
—
—
Returns
—
—
Loading...
1D
1W
1M
3M
6M
1Y
3Y
5Y
Max

Healthcare

Biotechnology

Micro Cap

With a market cap of $127.1M the stock is ranked 4541

Key Metrics

Key Metrics

PE TTM
PE TTM

Close price divided by the earnings per share for the trailing twelve months

—
PB
PB

Close price divided by the book value per share at the end of the most recent quarter

0
EPS TTM
EPS TTM

Net profit earned per share over the trailing twelve months (sum of the last 4 quarters)

$-2.61
PEG Ratio
PEG Ratio

Price-to-Earnings (P/E) ratio divided by the forecasted annual earnings per share (EPS) growth rate over the next five years

—
Profit Margin
Profit Margin

Net profit divided by the total revenue for the most recent financial year

0%
Dividend Yield
Dividend Yield

Annual dividend per share for the trailing twelve months divided by the close price

—

Company Profile

Company Profile

Retension Pharmaceuticals, Inc. operates as a clinical -stage biopharmaceutical company focused on developing medicines for the treatment of hypertension and other cardiovascular diseases. It offers RTN -001, an oral, small molecule phosphodiesterase -5 inhibitor designed to reduce blood pressure by potentiating nitric oxide signaling. The Company operates as a single operating and reportable segment focused on the development of treatments for hypertension and cardiovascular disease. The company was incorporated in 2023 and is headquartered in Falls Church, Virginia.
Retension Pharmaceuticals, Inc. operates as a clinical -stage biopharmaceutical company focused on developing medicines for the treatment of hypertension and other cardiovascular diseases. It offers RTN -001, an oral, small molecule phosphodiesterase -5 inhibitor designed to reduce blood pressure by potentiating nitric oxide signaling. The Company operates as a single operating and reportable segment focused on the development of treatments for hypertension and cardiovascular disease. The company was incorporated in 2023 and is headquartered in Falls Church, Virginia.

Forecast

Forecast

empty forecast

Forecast data is currently unavailable

Forecast data is currently unavailable

Price

Price Upside

Revenue

Revenue Growth

Earnings

Earnings Per Share

Financials

Financials

Income

Balance Sheet

Cash Flow

Q4 2025
Q2 2026
Revenue
Net Income
Financial YearQ4 2025Q2 2026
Total Revenue--
Net Income--
Net Profit Margin--
See CostsAll values in $ Billion

Peers

Price Comparison

Compare RTSN with any stocks or ETF

Hmm, looks like data is currently unavailable. Once it's updated, you can view it here

Frequently asked questions

  1. Retension Pharmaceuticals, Inc. Common Stock (RTSN) share price today is $14.59 as of October 27, 2026 at 12:52 AM IST. The stock touched a day high of $15.60 and a day low of $14.35.

  2. Retension Pharmaceuticals, Inc. Common Stock stock trades on NASDAQ under the ticker symbol RTSN.

  3. Retension Pharmaceuticals, Inc. Common Stock's market capitalization is $127.05M as of October 27, 2026 at 12:52 AM IST.

  4. Retension Pharmaceuticals, Inc. Common Stock's price-to-earnings (P/E) ratio is N/A as of October 26, 2026.

  5. Retension Pharmaceuticals, Inc. Common Stock's price-to-book (P/B) ratio is 0 as of October 26, 2026.

  6. Yes, You can buy Retension Pharmaceuticals, Inc. Common Stock shares from India through Tickertape, via our partnership with ViewTrade IFSC under the IFSCA Global Access framework, subject to RBI’s Liberalised Remittance Scheme (LRS) limits.

  7. Indian investors can buy Retension Pharmaceuticals, Inc. Common Stock shares in three steps: 1. Search Retension Pharmaceuticals, Inc. Common Stock on the Tickertape app and tap Invest. 2. Complete your one-time digital KYC. 3. Fund your account and buy from as low as $1 via fractional shares.

  8. Since Retension Pharmaceuticals, Inc. Common Stock trades in USD, an Indian investor's INR returns depend on both the stock's price movement and the USD-INR exchange rate. If the rupee depreciates against the dollar, INR returns are boosted beyond the stock's USD return; if the rupee appreciates, INR returns are reduced.

  9. Indian investors can start investing in Retension Pharmaceuticals, Inc. Common Stock (RTSN) shares from as little as $1 through fractional ownership on Tickertape - for example, $10 buys approximately 0.6854 shares at the current price of $14.59.

Loading...